{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:19:57Z","timestamp":1790432397678,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Marie Curie Initial Training Network PathChooser","award":["PITNGA-2013-608373"],"award-info":[{"award-number":["PITNGA-2013-608373"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejpb.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T01:48:22Z","timestamp":1491011302000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus"],"prefix":"10.1016","volume":"118","author":[{"given":"Xabi","family":"Murgia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzey","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Carvalho-Wodarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"Loretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Schwarzkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Michael","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.03.020_b0005","first-page":"761","article-title":"Physiology of airway mucus clearance","volume":"47","author":"Rubin","year":"2002","journal-title":"Respir. Care"},{"key":"10.1016\/j.ejpb.2017.03.020_b0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(13)70072-9","article-title":"Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges","volume":"1","author":"Ruge","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejpb.2017.03.020_b0015","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2017.03.020_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/ACI.0b013e3280114eef","article-title":"Mucociliary clearance \u2013 a critical upper airway host defense mechanism and methods of assessment","volume":"7","author":"Antunes","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2017.03.020_b0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1223012","article-title":"A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia","volume":"337","author":"Button","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2017.03.020_b0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2017.03.020_b0035","first-page":"139","article-title":"Clinical issues of mucus accumulation in COPD","volume":"9","author":"Ramos","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.ejpb.2017.03.020_b0040","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1164\/ajrccm.162.5.9909009","article-title":"Cystic fibrosis sputum: a barrier to the transport of nanospheres","volume":"162","author":"Sanders","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2017.03.020_b0045","doi-asserted-by":"crossref","first-page":"276ra227","DOI":"10.1126\/scitranslmed.3010525","article-title":"Oxidation increases mucin polymer cross-links to stiffen airway mucus gels","volume":"7","author":"Yuan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2017.03.020_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1164\/rccm.200807-1056OC","article-title":"Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma","volume":"180","author":"Innes","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2017.03.020_b0055","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2017.03.020_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.01.083","article-title":"Chitosan as a non-viral co-transfection system in a cystic fibrosis cell line","volume":"502","author":"Fernandez Fernandez","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2012.09.020","article-title":"Surface modified poly(beta amino ester)-containing nanoparticles for plasmid DNA delivery","volume":"164","author":"Fields","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejpb.2017.03.020_b0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jgm.2748","article-title":"Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy","volume":"15","author":"Bangel-Ruland","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ejpb.2017.03.020_b0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00441-005-0062-7","article-title":"Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o","volume":"323","author":"Ehrhardt","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejpb.2017.03.020_b0080","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3390\/v5092260","article-title":"Respiratory syncytial virus infection disrupts monolayer integrity and function in cystic fibrosis airway cells","volume":"5","author":"Kong","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.ejpb.2017.03.020_b0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yexmp.2009.09.018","article-title":"CFTR and tight junctions in cultured bronchial epithelial cells","volume":"88","author":"Nilsson","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejpb.2017.03.020_b0090","doi-asserted-by":"crossref","first-page":"e100621","DOI":"10.1371\/journal.pone.0100621","article-title":"Paracellular transport through healthy and cystic fibrosis bronchial epithelial cell lines \u2013 do we have a proper model?","volume":"9","author":"Molenda","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2017.03.020_b0095","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.03.020_b0100","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3109\/03639041003695113","article-title":"Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model","volume":"36","author":"Haghi","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0105","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1021\/bm201226x","article-title":"Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells","volume":"12","author":"Mura","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2017.03.020_b0110","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/acs.biomac.6b00164","article-title":"Size-limited penetration of nanoparticles into porcine respiratory mucus after aerosol deposition","volume":"17","author":"Murgia","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2017.03.020_b0115","doi-asserted-by":"crossref","first-page":"18355","DOI":"10.1073\/pnas.1214066109","article-title":"Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus","volume":"109","author":"Kirch","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2017.03.020_b0120","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1089\/jamp.2010.0836","article-title":"The particle has landed \u2013 characterizing the fate of inhaled pharmaceuticals","volume":"23","author":"Patton","year":"2010","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejpb.2017.03.020_b0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","article-title":"Mucus as a barrier to lipophilic drugs","volume":"453","author":"Sigurdsson","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0130","doi-asserted-by":"crossref","first-page":"e51054","DOI":"10.1371\/journal.pone.0051054","article-title":"Immobilization of pseudorabies virus in porcine tracheal respiratory mucus revealed by single particle tracking","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2017.03.020_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2009.07.028","article-title":"Ionically crosslinked chitosan\/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery","volume":"382","author":"Csaba","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","article-title":"Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency","volume":"70","author":"Mao","year":"2001","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejpb.2017.03.020_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00253-003-1321-8","article-title":"Non-viral gene therapy: polycation-mediated DNA delivery","volume":"62","author":"Thomas","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejpb.2017.03.020_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1378\/chest.98.1.101","article-title":"General anesthesia does not alter the viscoelastic or transport properties of human respiratory mucus","volume":"98","author":"Rubin","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.ejpb.2017.03.020_b0155","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/ajrccm\/141.4_Pt_1.1040","article-title":"Collection and analysis of respiratory mucus from subjects without lung disease","volume":"141","author":"Rubin","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejpb.2017.03.020_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2014.08.009","article-title":"Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation","volume":"11","author":"Mittal","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2017.03.020_b0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2009.04.049","article-title":"Relevance of the colloidal stability of chitosan\/PLGA nanoparticles on their cytotoxicity profile","volume":"381","author":"Nafee","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1517\/17425255.4.4.333","article-title":"In vitro cell culture models for the assessment of pulmonary drug disposition","volume":"4","author":"Sporty","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejpb.2017.03.020_b0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11095-014-1494-0","article-title":"The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model","volume":"32","author":"Kreft","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.03.020_b0180","first-page":"L951","article-title":"Vectorial transcytosis of dimeric IgA by the Calu-3 human lung epithelial cell line: upregulation by IFN-gamma","volume":"272","author":"Loman","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejpb.2017.03.020_b0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/089426802320282257","article-title":"Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers","volume":"15","author":"Ehrhardt","year":"2002","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.ejpb.2017.03.020_b0190","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm\/141.5_Pt_1.1107","article-title":"Tracheal mucus rheology in patients undergoing diagnostic bronchoscopy. Interrelations with smoking and cancer","volume":"141","author":"Zayas","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejpb.2017.03.020_b0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2014.01.001","article-title":"Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption","volume":"87","author":"Boegh","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2012.10.021","article-title":"The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model","volume":"84","author":"Teubl","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.03.020_b0205","first-page":"251","article-title":"Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier","volume":"33","author":"Kuehn","year":"2016","journal-title":"Altex"},{"key":"10.1016\/j.ejpb.2017.03.020_b0210","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/labinvest.3700081","article-title":"Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro","volume":"84","author":"Hermanns","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejpb.2017.03.020_b0215","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.03.020_b0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.03.020_b0225","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nbt.3241","article-title":"In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency","volume":"33","author":"Mahiny","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2017.03.020_b0230","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.biomaterials.2003.08.069","article-title":"Preparation and characterization of cationic PLGA nanospheres as DNA carriers","volume":"25","author":"Kumar","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2017.03.020_b0235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.lungcan.2009.07.010","article-title":"Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells","volume":"68","author":"Beisner","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejpb.2017.03.020_b0240","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1208\/pt050467","article-title":"Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods","volume":"5","author":"Dhawan","year":"2004","journal-title":"AAPS PharmSciTech"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T10:00:03Z","timestamp":1568973603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117304010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":48,"alternative-id":["S0939641117304010"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.03.020","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}